Get the Stockscreener App
1.53
3.77%
-0.06
Pre-market:
1.53
Nucana Plc Adr stock is traded at $1.53, with a volume of 152.14K.
It is down -3.77% in the last 24 hours and down -31.70% over the past month.
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
See More
Previous Close:
$1.59
Open:
$1.55
24h Volume:
152.14K
Relative Volume:
2.51
Market Cap:
$6.37M
Revenue:
-
Net Income/Loss:
$-36.52M
P/E Ratio:
-0.00937
EPS:
-163.3522
Net Cash Flow:
$-18.20M
1W Performance:
-12.07%
1M Performance:
-31.70%
6M Performance:
-61.56%
1Y Performance:
-99.04%
1-Day Range:
$1.42
$1.5796
1-Week Range:
$1.42
$1.7472
52-Week Range:
$1.42
$268.00
Nucana Plc Adr Stock (NCNA) Company Profile
Compare NCNA vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NCNA
Nucana Plc Adr
|
1.53 | 6.62M | 0 | -36.52M | -18.20M | -163.35 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-30-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-03-22 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-22-20 | Initiated | Truist | Buy |
| Jul-24-20 | Initiated | Oppenheimer | Outperform |
| Aug-19-19 | Initiated | H.C. Wainwright | Buy |
| Oct-19-18 | Initiated | Piper Jaffray | Overweight |
| Oct-23-17 | Initiated | Citigroup | Buy |
| Oct-23-17 | Initiated | Jefferies | Buy |
| Oct-23-17 | Initiated | William Blair | Outperform |
View All
Nucana Plc Adr Stock (NCNA) Latest News
-3.18% for NuCana stock as price stays pinned below key support levels - Traders Union
What triggered NuCana shares' latest price pullback - Traders Union
Negative indicators push NuCana stock lower amid continued selling activity - Traders Union
Selling pressure pushes NuCana stock lower in today's trading - Traders Union
Unusual Machines, NuCana, Navigator Holdings and other big stocks moving lower in Friday's pre-market session - MSN
What is behind NuCana stock's recent gain in value today - Traders Union
Technical weakness and oversold signals: NuCana stock falls 3.22% - Traders Union
NuCana shares see a dip: what is pressuring the stock - Traders Union
Unusual Machines, NuCana, Navigator Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
NuCana (NASDAQ: NCNA) outlines 2025 losses, cash and oncology pipeline risks - Stock Titan
Why is NuCana ADR stock down today? - Traders Union
Bearish technicals, heavy selling: NuCana stock slips 3.10% - Traders Union
NuCana stock slips 4.3% as bearish momentum builds ahead of earnings - Traders Union
Sustained bearish momentum and oversold signals — NuCana stock gains 3.14% - Traders Union
Why is NuCana stock up today? - Traders Union
NuCana shares see a dip — What is pressuring the stock - Traders Union
NuCana stock: Persistent volatility and downside risk drive further weakness - Traders Union
Oversold signals and resistance at $2.29 — NuCana stock gains 3.08% - Traders Union
NuCana shares see a jump — What is fueling the stock rise - Traders Union
Bearish technical signals persist — NuCana stock drops 3.52% - Traders Union
Persistent bearish signals and technical resistance — NuCana stock drops 4.63% - Traders Union
NuCana sees a dip — What is pressuring the stock - Traders Union
NuCana stock price forecast: Bear signals weigh as NCNA dips beneath key levels - Traders Union
NCNA Fundamental Analysis | NUCANA PLC-ADR (NASDAQ:NCNA) - ChartMill
Weak technical signals and persistent selling — NuCana stock falls 4.02% - Traders Union
What is behind NuCana recent drop in value today - Traders Union
What triggered NuCana latest price surge - Traders Union
NuCana stock: persistent negative momentum drives 3.40% gain despite mixed technicals - Traders Union
NuCana climbs today: Key reasons behind the rally - Traders Union
Buying pressure lifts NuCana higher in today trading - Traders Union
NuCana slides today: Key reasons behind the decline - Traders Union
NuCana stock price forecast: Further downside risk as NCNA drops 3.75% near support levels - Traders Union
NuCana stock: Bearish trends and weak support drive continued price decline - Traders Union
Deeply oversold RSI and bearish technicals — NuCana stock gains 3% - Traders Union
-5.76% for NuCana stock — oversold levels signal persistent bearish pressure - Traders Union
-5.45% for NuCana stock — technical signals warn of limited upside potential - Traders Union
Here’s why NuCana is sliding (January 26) - Traders Union
NuCana is falling today: what traders are watching (January 9) - Traders Union
NuCana stock price forecast: Sellers remain in control as NCNA edges toward support - Traders Union
NuCana stock drops 2.16% as sellers dominate below key moving averages - Traders Union
NuCana stock price forecast: rangebound days expected as NCNA holds steady near resistance - Traders Union
NuCana Appoints Theresa Bruce as Chief Operating Officer - GlobeNewswire Inc.
NuCana appoints Theresa Bruce as chief operating officer - Investing.com
NuCana (NASDAQ:NCNA) Trading Up 1.6% – Here’s Why - Defense World
NuCana plc ADR (NCNA) Stock Price Prediction for 2026, 2030-2040 - Traders Union
NuCana plc ADR (NCNA) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
NuCana reports partial responses in melanoma treatment trial - Investing.com
NuCana stock rises after securing key patent in China for cancer drug - Investing.com
Taking the lead: NuCana plc ADR (NCNA) - Setenews
NuCana regains Nasdaq compliance, extends cash runway into 2029 - Investing.com
Wall Street Today: Dow, Nasdaq, S&P 500 open flat as investors focus on China tariff deadline; Nvidia down 1.3% - Mint
Nucana Plc Adr Stock (NCNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):